JPMorgan Chase & Co. Lowers Recursion Pharmaceuticals (NASDAQ:RXRX) Price Target to $10.00
Recursion Pharmaceuticals (NASDAQ:RXRX – Free Report) had its target price decreased by JPMorgan Chase & Co. from $11.00 to $10.00 in a research note issued to investors on Monday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. Separately, Needham & Company LLC decreased their target price on Recursion Pharmaceuticals […]
More Stories
IMPACTfolio LLC Reduces Holdings in Zoetis Inc. (NYSE:ZTS)
IMPACTfolio LLC lessened its holdings in shares of Zoetis Inc. (NYSE:ZTS – Free Report) by 4.4% during the 4th quarter,...
Peirce Capital Management LLC Decreases Holdings in Dimensional US Marketwide Value ETF (NYSEARCA:DFUV)
Peirce Capital Management LLC lessened its holdings in shares of Dimensional US Marketwide Value ETF (NYSEARCA:DFUV – Free Report) by...
Quantum-Si (NASDAQ:QSI) Trading 39.6% Higher – Here’s Why
Quantum-Si incorporated (NASDAQ:QSI – Get Free Report)’s stock price was up 39.6% during trading on Thursday . The stock traded...
PepsiCo Target of Unusually Large Options Trading (NASDAQ:PEP)
PepsiCo, Inc. (NASDAQ:PEP – Get Free Report) saw some unusual options trading on Thursday. Stock investors purchased 33,914 put options...
Algold Resources Ltd. (ALG.V) (CVE:ALG) Trading Down 3.3% – Time to Sell?
Algold Resources Ltd. (ALG.V) (CVE:ALG – Get Free Report) shares were down 3.3% during mid-day trading on Tuesday . The...
Distillate U.S. Fundamental Stability & Value ETF (NYSEARCA:DSTL) Trading 0.1% Higher – Still a Buy?
Shares of Distillate U.S. Fundamental Stability & Value ETF (NYSEARCA:DSTL – Get Free Report) shot up 0.1% during trading on...